Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-087937

Chief Operating Officer sold 100,000 shares at an average $19.29 ($1,929,141)

  • Chief Operating Officer acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kling Douglas F Chief Operating Officer 2025-06-16 Option exercise 10b5-1 +78,101 $10.00 $781,010 122,101 D: show line 1 in the form
Kling Douglas F Chief Operating Officer 2025-06-16 Option exercise 10b5-1 +21,899 $10.90 $238,699 144,000 D: show line 2 in the form
Kling Douglas F Chief Operating Officer 2025-06-16 Sale 10b5-1 −81,891 $19.19 $1,571,488 62,109 D: show line 3 in the form
Kling Douglas F Chief Operating Officer 2025-06-16 Sale 10b5-1 −18,109 $19.75 $357,653 44,000 D: show line 4 in the form
Open-market sales · 100,000 sh · avg $19.29 · $1,929,141

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kling Douglas F Chief Operating Officer 2025-06-16 Option exercise · Option (right to buy) 10b5-1 −78,101 372,829 D: show line 5 in the form
Kling Douglas F Chief Operating Officer 2025-06-16 Option exercise · Option (right to buy) 10b5-1 −21,899 261,314 D: show line 6 in the form
Loading xslF345X05/ownership.xml…